All data are based on the daily closing price as of September 6, 2024
s
Seegene
096530.KQ
18.82 USD
-0.01
-0.05%
Overview
Last close
18.82 usd
Market cap
869.59M usd
52 week high
25.77 usd
52 week low
13.86 usd
Target price
38.92 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
3.0205
Price/Book Value
1.1105
Enterprise Value
582.60M usd
EV/Revenue
2.0369
EV/EBITDA
7.7846
Key financials
Revenue TTM
286.02M usd
Gross Profit TTM
370.96M usd
EBITDA TTM
34.94M usd
Earnings per Share
N/A usd
Dividend
0.6 usd
Total assets
1,267.64B usd
Net debt
N/A usd
About
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.